MedTrace Logo

To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy

NCT02441439 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-11-08

No results posted yet for this study

Summary

This study is aimed to compare the efficacy of 2 doses of iron sucrose given intravenously - 200 mg versus 500 mg.

Conditions

  • Pregnancy

Interventions

DIETARY_SUPPLEMENT

Iron sucrose 200 mg

I.V Iron sucrose 200 mg 2-3 times per week. Each time for 20-30 minutes

DIETARY_SUPPLEMENT

Iron sucrose 500 mg

I.V Iron sucrose 500 mg once per week. Each time for 3.5 hours

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-11-07
Completion
2022-11-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02441439 on ClinicalTrials.gov